Drug Safety Symposium 2025: The Eminence Touch - Combining Learning, Networking & Fun in Dubai

Drug Safety Symposium 2025: The Eminence Touch - Combining Learning, Networking & Fun in Dubai

India Pharma Outlook Team | Thursday, 12 December 2024

 Drug Safety Symposium 2025: The Eminence Touch - Combining Learning, Networking & Fun in Dubai

The 3rd Edition Drug Safety Symposium 2025 – Dubai Chapter, taking place on February 12th –13th, 2025, is set to be an extraordinary event that not only builds on the successes of its previous editions but also introduces something even more exciting. Known for bringing fun and learning together, Eminence Group is adding its signature flair to this year’s event, making it not just a platform for deep industry insights but an engaging and dynamic experience.

After two highly successful editions in Dubai and Mumbai in 2024, the 3rd Edition Drug Safety Symposium 2025 – Dubai Chapter will be grander in scale, featuring a more diverse set of topics, an expanded global speaker lineup, and plenty of interactive elements to ensure delegates leave with practical knowledge—and a memorable experience.

The Legacy of Success: Dubai and Mumbai Editions

Over the past year, the Drug Safety Symposium has become a must-attend event for professionals in the fields of pharmacovigilance, drug safety, and regulatory affairs. The Dubai Chapter in 2024 marked the symposium's debut with a carefully curated agenda that set the tone for its reputation as a high-caliber event. Leading regulators, pharma executives, and thought leaders from across the globe gathered to share their expertise on critical topics such as risk management, drug safety monitoring, and regulatory compliance. The event received praise for its organization and the quality of its discussions.

In June 2024, the Mumbai Chapter took things to a new level. The agenda was expanded to cover emerging challenges in pharmacovigilance, including evolving regulatory landscapes and the use of artificial intelligence in drug monitoring. The event successfully attracted a broader audience, with participants from various sectors contributing to dynamic panel discussions, case studies, and workshops.

Now, the 3rd Edition Drug Safety Symposium 2025 – Dubai Chapter aims to raise the bar even higher. With the Eminence Touch, the focus will not just be on learning but also on creating an environment where fun, interaction, and creativity go hand-in-hand with knowledge sharing.

Global Experts, Local Insights

One of the hallmarks of the Drug Safety Symposium is its ability to attract world-class speakers, and the 3rd Edition Drug Safety Symposium 2025 – Dubai Chapter will be no exception. Eminence Group has curated a lineup of global experts who will provide invaluable insights into the latest compliance requirements and discuss how emerging trends are reshaping global pharmacovigilance practices.

The 3rd Edition Drug Safety Symposium 2025 – Dubai Chapter will also feature senior executives from leading pharma companies who will share their experiences with implementing innovative drug safety strategies. These speakers will address a wide range of critical topics, from leveraging artificial intelligence to manage adverse drug events to navigating the complexities of global regulatory changes.

Adding to the excitement, there will be sessions delivered by top academics and industry leaders from renowned institutions, offering fresh perspectives on patient safety, clinical trials, and drug monitoring innovations. These diverse speakers ensure that every attendee, whether from industry, academia, or regulation, will find the content both relevant and impactful.

The Eminence Touch: Fun Meets Learning

What sets the 3rd Edition Drug Safety Symposium 2025 apart is its unique approach to blending serious learning with engaging activities. With the Eminence Touch, expect a symposium that breaks away from traditional conference formats. Eminence believes that fun enhances learning, and they've crafted an agenda that reflects this philosophy.

Throughout the two-day event, there will be a mix of interactive workshops, pop quizzes, and team-based activities designed to make learning more dynamic and enjoyable. These elements encourage participation, foster creativity, and make complex topics easier to understand through a hands-on approach.

One of the highlights of the event will be the interactive panel discussions where attendees can ask questions directly to speakers in real-time, allowing for personalized learning experiences. Additionally, Eminence incorporates a gamification element, with prizes for participants who actively engage in sessions, creating a friendly competitive environment that fosters collaboration and teamwork.

The 3rd Edition Drug Safety Symposium 2025 – Dubai Chapter will also include networking games and lighthearted social sessions, designed to break the ice and encourage attendees to form lasting professional connections. From brainstorming sessions to informal networking during coffee breaks, Eminence ensures that the event is as enjoyable as it is educational.

Comprehensive Agenda for All

The symposium’s agenda is packed with content that will resonate with a wide range of professionals in the pharmaceutical and healthcare industries. Topics will include pharmacovigilance best practices, updates on global regulatory standards, adverse event reporting systems, and risk-benefit analysis. With sessions designed to address the specific challenges of emerging markets, such as the Middle East and Africa, attendees will gain understanding that will shape their PV journey.  

Networking with a Purpose

Of course, a key component of the Eminence Touch is the emphasis on creating meaningful connections. The symposium will offer numerous opportunities for informal networking, from dedicated meet-and-greet sessions to a grand gala dinner, where attendees can unwind and engage in more relaxed conversations with their peers. The event will bring together 100+ professionals from over 10 countries, fostering cross-border collaborations and the exchange of diverse ideas.

Join Us for the 3rd Edition Drug Safety Symposium 2025 – Dubai Chapter

3rd Edition Drug Safety Symposium 2025 – Dubai Chapter is shaping up to be the largest and most engaging event in pharmacovigilance to date. If you’re looking to expand your knowledge, engage with global experts, and enjoy a few surprises along the way, this is the event for you.

Source: Press Release

on the deck

Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Related Articles


© 2025 India Pharma Outlook. All Rights Reserved.